Literature DB >> 10416986

High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors.

V M Hayes1, C M Dirven, A Dam, E Verlind, W M Molenaar, J J Mooij, R M Hofstra, C H Buys.   

Abstract

In adults, the TP53 tumor suppressor gene is frequently mutated in astrocytic brain tumors which is supposed to represent an early event in their development. In juvenile pilocytic and low-grade astrocytomas, however, TP53 mutations have until now been reported as rare, which has led to the suggestion that these tumors may follow a different molecular pathogenesis with an involvement of genes other than TP53. Our analysis of 20 pilocytic and two low-grade astrocytomas of childhood, based on a comprehensive denaturing gradient gel electrophoresis (DGGE) mutation detection assay of the entire coding region, including all splice site junctions of TP53, showed mutations considered as causative in 7 of the 20 (35%) pilocytic astrocytomas and in one of the two low-grade astrocytomas. Our finding is significantly different from the mutation frequency of 1.3% (2/155) previously reported for these tumor types. This may be attributed to the mutation detection system used, which also detects mutations occurring outside the evolutionary conserved region of TP53. Our results suggest that, contrary to the present notion, TP53 mutations may well play a role in the development of juvenile astrocytomas. Furthermore, no mutations were found in tumors of patients with progression of residual tumor after postoperative follow-up. This suggests that TP53 mutations may be associated with less aggressive forms of juvenile astrocytomas, analogous to the situation in adult astrocytomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416986     DOI: 10.1111/j.1750-3639.1999.tb00535.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  17 in total

1.  Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas.

Authors:  Craig Horbinski; Ronald L Hamilton; Yuri Nikiforov; Ian F Pollack
Journal:  Acta Neuropathol       Date:  2010-01-01       Impact factor: 17.088

2.  Acetylation of the p53 DNA-binding domain regulates apoptosis induction.

Authors:  Stephen M Sykes; Hestia S Mellert; Marc A Holbert; Keqin Li; Ronen Marmorstein; William S Lane; Steven B McMahon
Journal:  Mol Cell       Date:  2006-12-28       Impact factor: 17.970

Review 3.  Molecular pathogenesis of childhood brain tumors.

Authors:  Torsten Pietsch; Michael D Taylor; James T Rutka
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

4.  Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.

Authors:  Da Yong Lee; Scott M Gianino; David H Gutmann
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

Review 5.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

Review 6.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

7.  Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.

Authors:  Nicola Potter; Aikaterini Karakoula; Kim P Phipps; William Harkness; Richard Hayward; Dominic N P Thompson; Thomas S Jacques; Brian Harding; David G T Thomas; Rodger W Palmer; Jeremy Rees; John Darling; Tracy J Warr
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

Review 8.  Pathology and molecular genetics of astrocytic gliomas.

Authors:  Guido Reifenberger; Vincent Peter Collins
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

9.  P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.

Authors:  Fang He; Yi Xia; Huafeng Liu; Jin Li; Chao Wang
Journal:  Tumour Biol       Date:  2013-07-17

10.  K120R mutation inactivates p53 by creating an aberrant splice site leading to nonsense-mediated mRNA decay.

Authors:  Seo-Young Lee; Jung-Hyun Park; Sangkyun Jeong; Bu-Yeo Kim; Yong-Kook Kang; Yang Xu; Sun-Ku Chung
Journal:  Oncogene       Date:  2018-10-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.